However, several studies have provided evidence that 9p UPD can occur prior to JAK2‐V617F in up to 10% of MPN patients, indicating that there might be a second target of this chromosomal aberration.44, 45. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.